Molecular basis for resistance to the anticancer drug cisplatin in Dictyostelium

Guochun Li1, Hannah Alexander1, Natalie Schneider2

  • 1Division of Biological Sciences, University of Missouri, Columbia, MO 65211, USA1.

Insights

Researchers identified six novel genes involved in cisplatin resistance using Dictyostelium discoideum. These genes, some linked to cell signaling and development, offer new targets for overcoming chemotherapy resistance.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cell Biology

Background:

  • Cisplatin is a widely used chemotherapy drug.
  • Drug-resistant tumor cells limit cisplatin efficacy.
  • Understanding cisplatin resistance mechanisms is crucial for cancer therapy.

Purpose of the Study:

  • Identify novel genes involved in cisplatin resistance.
  • Investigate the molecular basis of cisplatin resistance.
  • Explore potential therapeutic targets for overcoming cisplatin resistance.

Main Methods:

  • Insertional mutagenesis technique in Dictyostelium discoideum.
  • Identification and characterization of six novel genes conferring cisplatin resistance.
  • Analysis of gene function in relation to cell signaling, cell death, proliferation, gene regulation, and multicellular development.

Main Results:

  • Six previously unknown genes involved in cisplatin resistance were identified.
  • Resistance conferred by these genes is specific to cisplatin.
  • Disruption of three genes (sphingosine-1-phosphate lyase, RegA cAMP phosphodiesterase, phosphatidylinositol-4-phosphate 5-kinase) affects multicellular development without impacting cell growth rate.
  • Identified novel molecular pathways regulating cellular response to cisplatin and morphogenesis.

Conclusions:

  • Novel molecular pathways involved in cisplatin resistance and development have been uncovered.
  • These pathways represent potential targets for modulating cisplatin response in cancer therapy.
  • The study highlights the complexity of cellular responses to cisplatin and its impact on cellular processes beyond proliferation.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Other Unique Bacteria01:18

Other Unique Bacteria

Magnetic bacteria exhibit a directed movement called magnetotaxis, driven by structures called magnetosomes. These magnetosomes consist of chains of magnetic particles made of either magnetite (Fe₃O₄) or greigite (Fe₃S₄) and are organized in a linear conformation by a protein scaffold within invaginations of the cell membrane. The bacteria align along the north–south magnetic field lines, much like a compass needle. They are typically microaerophilic or anaerobic and are commonly found near the...